Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery

URN:NBN:SI:DOC-2SLIB3RD2026Boltežar, LučkaFujs Komloš, KristinaIhan, AlojzJevnikar, SaraJurca, TomažMlakar-Mastnak, DenisOcvirk, JanjaOražem, MihaPohar, KatkaPoljak, MarioRotovnik-Kozjek, NadaVratanar, Bordocuments/doc/2/URN_NBN_SI_doc-2SLIB3RD_001.pdfdocuments/doc/2/URN_NBN_SI_doc-2SLIB3RD_001.txt160articlestr. 76-851318-2099276354563URN:NBN:SI:doc-2SLIB3RDengCroatian Medical Association - Croatian Society of RadiologySlovenian Medical Society - Section of RadiologyRadiology and oncology (Ljubljana)BYB-celični limfomB-cellcepljenje proti covid-19COVID-19 vaccineslimfomlymphomarituksimabrituximabImpaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery